Skip to main content
Clinical Trials/JPRN-UMIN000028962
JPRN-UMIN000028962
Recruiting
未知

Comparative study of symptom improvement effect of vonoprazan and esomeprazole in patients with reflux esophagitis. - Study of symptom improvement effect of gastric secretion inhibitors in patients with reflux esophagitis.

Ikoma Gastorenteroproctorogy Clinic0 sites40 target enrollmentSeptember 1, 2017

Overview

Phase
未知
Intervention
Not specified
Conditions
Reflex esophagitis
Sponsor
Ikoma Gastorenteroproctorogy Clinic
Enrollment
40
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 1, 2017
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Ikoma Gastorenteroproctorogy Clinic

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\.The patients with warning signs such as vomiting, gastrointestinal bleeding and sudden weight loss. 2\.The patients with confirmed or suspected malignant diseases. 3\.The patients with a history of gastrointestinal resection of vagotomy. 4\.The patients with a history of irritable bowel syndrome. 5\.The patients whose participation in this study would be contraindicated due to complications such as serious heaptic, renal or heart disease. 6\.The Pregnant patients or possibly pregnant patients. 7\.The patients prohibited the participant of this study by their attending physicians. 8\.The patients who took esomeprazole or vonoprazan within 4 weeks.

Outcomes

Primary Outcomes

Not specified

Similar Trials